Stock 4894 CUORIPS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Cuorips Inc.

Equities

4894

JP3266030000

Pharmaceuticals

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-05-22 am EDT 		5-day change 1st Jan Change
3,010 JPY -3.68% Intraday chart for Cuorips Inc. 0.00% +29.69%
2023 Certain Common Shares of Cuorips Inc. are subject to a Lock-Up Agreement Ending on 23-DEC-2023. CI
2023 Certain Common Shares of Cuorips Inc. are subject to a Lock-Up Agreement Ending on 24-SEP-2023. CI

Income Statement Evolution (Annual data)

Fiscal Period: März 2021 2022 2023
Net sales - 13 38
EBITDA - - -
EBIT 1 -281 -373 -450
Operating Margin - -2,869.23% -1,184.21%
Earnings before Tax (EBT) 1 -296 -373 -450
Net income 1 -307 -375 -452
Net margin - -2,884.62% -1,189.47%
EPS 2 -123.3 -66.54 -79.89
Free Cash Flow - - -
FCF margin - - -
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share - - -
Announcement Date 5/23/23 5/23/23 5/23/23
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2024 Q1 2024 S1
Net sales 1 3 11
EBITDA - -
EBIT 1 -133 -290
Operating Margin -4,433.33% -2,636.36%
Earnings before Tax (EBT) 1 -166 -326
Net income 1 -166 -327
Net margin -5,533.33% -2,972.73%
EPS 2 -28.38 -47.93
Dividend per Share - -
Announcement Date 8/10/23 11/10/23
1JPY in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: March 2021 2022 2023
Net Debt 1 - - -
Net Cash position 1 3,542 3,341 2,941
Leverage (Debt/EBITDA) - - -
Free Cash Flow - - -
ROE (net income / shareholders' equity) - -9.24% -12.3%
ROA (Net income/ Total Assets) - -5.55% -7.37%
Assets 1 - 6,762 6,132
Book Value Per Share 2 1,696 691.0 610.0
Cash Flow per Share 2 1,423 593.0 520.0
Capex - - -
Capex / Sales - - -
Announcement Date 5/23/23 5/23/23 5/23/23
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
CUORIPS INC. Stock Cuorips Inc.
+29.69% 159M
CSL LIMITED Stock CSL Limited
-2.99% 89.49B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+2.50% 40.67B
BIOGEN INC. Stock Biogen Inc.
-12.01% 33.15B
UCB Stock UCB
+63.24% 26.45B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-19.79% 14.69B
INCYTE CORPORATION Stock Incyte Corporation
-8.58% 12.89B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-12.34% 11.54B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-43.92% 11.34B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+3.82% 8.84B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 4894 Stock
  4. Financials Cuorips Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW